Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/2003
07/09/2003EP1325324A1 Improved anti-viral and anti-tumor chemotherapy by administration of erythropoeitin
07/09/2003EP1325153A2 Genetic determinants for dermal inflammation and immunity
07/09/2003EP1325152A2 Method for detecting pre-disposition to hepatotoxicity
07/09/2003EP1325144A2 Chromosomal vectors and uses thereof
07/09/2003EP1325134A2 Method to alter sugar moieties
07/09/2003EP1325125A2 Chromosome 3p21.3 genes are tumor suppressors
07/09/2003EP1325122A2 Modulation of the transcription of pro-inflammatory gene products
07/09/2003EP1325044A1 Aqueous polymer dispersion
07/09/2003EP1325025A1 Peptide-based gemini surfactant compounds facilitating the transfer into cells
07/09/2003EP1325019A1 Antisense modulation of clusterin expression
07/09/2003EP1325014A2 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers
07/09/2003EP1325010A1 Substituted 3.4-dihydro-pyrimido 1,2-a]pyrimidines and 3.4-dihydropyrazino 1,2-a]pyrimidines
07/09/2003EP1325009A2 Amino-substituted tetracyclic compounds useful as anti-inflammatory agents and pharmaceutical compositions comprising same
07/09/2003EP1325008A1 Piperazine derivatives
07/09/2003EP1325007A2 Hexahydropyrazino[1'2':1,6]-pyrido[3,4-b]indole-1,4-dione derivatives for the treatment of cardiovascular disorders and erectile disfunction
07/09/2003EP1325006A2 Heterocyclic compounds as ligands of the gaba a? receptor
07/09/2003EP1325005A1 1,2,5,10-tetrahydropyridazino 4,5-b]quinoline-1,10-diones and their use for the treatment of pain
07/09/2003EP1325004A1 1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-diones and their use for the treatment of pain
07/09/2003EP1325003A1 7-chloro-4-hydroxy-2-(2-pyridylethyl)-1,2,5,10-tetrahydropyridazino 4,5-b]quinoline-1,10-dione and the use thereof for the treatment of pain
07/09/2003EP1325002A1 1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-diones and their use for the treatment of pain
07/09/2003EP1325001A1 Anticholinergic agents that can be used as medicaments and method for the production thereof
07/09/2003EP1325000A1 A thiazolidinedione derivative and its use as antidiabetic
07/09/2003EP1324999A1 Novel aminophenyl piperazine or aminophenyl piperidine derivatives inhibiting prenyl transferase proteins and methods for preparing same
07/09/2003EP1324998A1 Novel aminotriazolone compounds, method for preparing same and pharmaceutical compositions containing same
07/09/2003EP1324997A2 Dioxolane analogs for improved inter-cellular delivery
07/09/2003EP1324995A2 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders
07/09/2003EP1324994A2 Tricyclic compounds and uses thereof
07/09/2003EP1324992A1 Cyclized benzamide neurokinin antagonists for use in therapy
07/09/2003EP1324991A1 Compounds useful in the treatment of inflammatory diseases
07/09/2003EP1324990A1 Morpholin-acetamide derivatives for the treatment of inflammatory diseases
07/09/2003EP1324986A1 Nitrogen-containing compounds and their use as glycine transport inhibitors
07/09/2003EP1324985A1 Inhibitors of prenyl-protein transferase
07/09/2003EP1324981A2 Aminopyridinyl-, aminoguanidinyl- and alkoxyguanidinyl- substituted phenyl acetamides as protease inhibitors
07/09/2003EP1324980A1 Citrullimycines, a process for their production and their use as pharmaceuticals
07/09/2003EP1324974A2 Drugs for diabetes
07/09/2003EP1324972A1 Dihydroxy open-acid salt of simvastatin
07/09/2003EP1324970A2 Retinoids for the treatment of emphysema
07/09/2003EP1324782A2 Stabilized hydrogen peroxide solutions
07/09/2003EP1324780A2 Cardiac arrhythmia treatment methods
07/09/2003EP1324774A2 Use of a ppar delta activator for treating inflammatory conditions
07/09/2003EP1324773A2 Use of a ppar delta activator in the treatment of diseases related to no inhibition or tnf inhibition
07/09/2003EP1324772A2 Methods for treating disorders of the female reproductive system
07/09/2003EP1324766A2 Methods and compositions for the treatment of peripheral artery disease
07/09/2003EP1324763A1 Stat3 agonists and antagonists and therapeutic uses thereof
07/09/2003EP1324761A2 Uridine therapy for patients with elevated purine levels
07/09/2003EP1324760A1 Creatine ester pronutrient compounds and formulations
07/09/2003EP1324759A2 Nf-g(k)b inhibitors
07/09/2003EP1324758A1 Method for preparing microspheres containing a water-soluble substance
07/09/2003EP1324757A1 Protein prenyl transferase inhibitors in the treatment of neuroinflammatory disease
07/09/2003EP1324756A2 Fatty acid analogues for the treatment of proliferative skin disorders
07/09/2003EP1324755A1 Pharmaceutical solutions of modafinil compounds
07/09/2003EP1324754A1 Pharmaceutical combination of an anti-androgen and tamoxifen for providing an anti-androgenic effect and aromatase inhibition
07/09/2003EP1324753A2 Compositions and methods for lowering plasma lipoprotein(a) and risk factors of cardiovascular diseases
07/09/2003EP1324750A1 Phosphatidylserine-carrying apoptosis-mimicking bodies and the use thereof in medical treatment
07/09/2003EP1324749A2 Medicinal aerosol formulations
07/09/2003EP1324748A1 Topical antibiotic composition for treatment of eye infection
07/09/2003EP1324663A1 Probes for targeting of cell density-indicating compounds
07/09/2003EP1235810B1 Process of making substituted pyrazoles
07/09/2003EP1200041A4 Sunscreen for the scalp and hair
07/09/2003EP1175210A4 Increasing cerebral bioavailability of drugs
07/09/2003EP1156798B1 Felbamate derived compounds
07/09/2003EP1098871B1 alpha-AMINO ACID PHENYL ESTER DERIVATIVES
07/09/2003EP1071752B1 CD19xCD3 SPECIFIC POLYPEPTIDES AND USES THEREOF
07/09/2003EP1066277B1 Polyethoxylated ascorbic acid derivatives as a novel antioxidant and process for preparing thereof
07/09/2003EP1040096B1 Neuroprotective agents
07/09/2003EP1031345B1 Gel preparation containing polystyrene-sulfonates
07/09/2003EP1009385B1 Cholesterol level lowering composition
07/09/2003EP1001778B1 Use of a rifamycin derivative for treating mastitis in a domestic animal
07/09/2003EP0994703B1 Composition comprising ketanserin and l-carnitine for the treatment of crps
07/09/2003EP0988306B1 3-substituted 3,4 dihydro-thieno 2, 3-d]pyrimidine derivatives and production and use of the same
07/09/2003EP0983262B1 Quinoline-4-carboxamide derivatives as nk-2 and nk-3 receptor antagonists
07/09/2003EP0973768B1 Azole compounds, their production and their use
07/09/2003EP0966465B1 Inhibitors of impdh enzyme
07/09/2003EP0948500B1 Cyclic organoselenium compounds, their preparation and their uses
07/09/2003EP0937067B1 1-(3-aminoindazol-5-yl)-3-phenylmethyl-cyclic ureas useful as hiv protease inhibitors
07/09/2003EP0912558B1 Substituted indazole derivatives and their use as phosphodiesterase (pde) type iv and tumor necrosis factor (tnf) inhibitors
07/09/2003EP0912557B1 Oxindole derivatives
07/09/2003EP0901483B1 Benzofurans and benzopyrans as chronobiological agents
07/09/2003EP0894004B1 Method for enhancing functional recovery of motor coordination, speech or sensory perception after central nervous system ischemia or trauma
07/09/2003EP0888353B1 N-7-HETEROCYCLYL PYRROLO [2,3-d]PYRIMIDINES AND THEIR USE
07/09/2003EP0868188B1 Kit for female mammals, comprising a combination of gestagen and oestrogen
07/09/2003EP0823906B1 Piperazino derivatives as neurokinin antagonists
07/09/2003EP0788307B1 Oligonucleotide modulation of the expression of multidrug resistance-associated protein
07/09/2003EP0752885B1 Therapeutic inhibitor of vascular smooth muscle cells
07/09/2003EP0717631B1 Immunomodulating compositions from bile
07/09/2003EP0612242B1 Use of the pure s(+) isomer of fluoxetine for the preparation of a medicament against migraine headache
07/09/2003EP0573576B2 Compositions for topical administration of pharmaceutically active agents
07/09/2003EP0190315B2 Dehydrated liposomes
07/09/2003CN1429273A Protection against environmental toxicity through manipulation of processing of messenger RNA precursors
07/09/2003CN1429233A Method of preparing clarithromycin of form II crystals
07/09/2003CN1429232A Use of azalide antibiotic compositions for treating or preventing bacterial or protozoal infection in mammals
07/09/2003CN1429226A Piperazine and piperidine compounds
07/09/2003CN1429225A C10 carbonate substituted taxanes as antitumor agents
07/09/2003CN1429222A 激酶抑制剂 Kinase inhibitors
07/09/2003CN1429221A 2-phenylpyran-4-one derivatives
07/09/2003CN1429220A Crystalline base of citalopram
07/09/2003CN1429219A Method for preparation of citalopram
07/09/2003CN1429215A 三唑衍生物 Triazole derivatives
07/09/2003CN1429213A Substituted caprolactam carbonates and ethers and their use as anti-tumor agents
07/09/2003CN1429212A Uses of thaliporphine or its derivatives in treatment of cardiac diseases and preparation of same